Eam Investors, LLC Novo Cure LTD Call Options Transaction History
Eam Investors, LLC
- $511 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
279Shares Held
73.4MCall Options Held
1.4MPut Options Held
389K-
Black Rock Inc. New York, NY12.1MShares$225 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$209 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$166 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$103 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$96.9 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.95B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...